Human Genome Epidemiology Literature Finder
Records 1 - 27 (of 27 Records) |
Query Trace: Sclerosis and IRF5[original query] |
---|
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Human molecular genetics 2008 Mar 17 (6): 872-81. Sigurdsson Snaevar, Göring Harald H H, Kristjansdottir Gudlaug, Milani Lili, Nordmark Gunnel, Sandling Johanna K, Eloranta Maija-Leena, Feng Di, Sangster-Guity Niquiche, Gunnarsson Iva, Svenungsson Elisabet, Sturfelt Gunnar, Jönsen Andreas, Truedsson Lennart, Barnes Betsy J, Alm Gunnar, Rönnblom Lars, Syvänen Ann-Christi |
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. Journal of medical genetics 2008 Jun 45 (6): 362-9. Kristjansdottir G, Sandling J K, Bonetti A, Roos I M, Milani L, Wang C, Gustafsdottir S M, Sigurdsson S, Lundmark A, Tienari P J, Koivisto K, Elovaara I, Pirttilä T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fernández O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syvänen A |
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis and rheumatism 2009 Aug 60 (8): 2472-9. Dieudé P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E, Granel B, Sibilia J, Tiev K, Mouthon L, Cracowski J L, Carpentier P H, Amoura Z, Fajardy I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore |
Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis and rheumatism 2009 Jun 60 (6): 1845-50. Ito Ikue, Kawaguchi Yasushi, Kawasaki Aya, Hasegawa Minoru, Ohashi Jun, Hikami Koki, Kawamoto Manabu, Fujimoto Manabu, Takehara Kazuhiko, Sato Shinichi, Hara Masako, Tsuchiya Naoyu |
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis and rheumatism 2009 Nov 60 (11): 3447-54. Dieudé P, Wipff J, Guedj M, Ruiz B, Melchers I, Hachulla E, Riemekasten G, Diot E, Hunzelmann N, Sibilia J, Tiev K, Mouthon L, Cracowski J L, Carpentier P H, Distler J, Amoura Z, Tarner I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore |
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. Journal of autoimmunity 2010 Mar 34 (2): 155-62. Gourh Pravitt, Agarwal Sandeep K, Martin Ezequiel, Divecha Dipal, Rueda Blanca, Bunting Haley, Assassi Shervin, Paz Gene, Shete Sanjay, McNearney Terry, Draeger Hilda, Reveille John D, Radstake T R D J, Simeon Carmen P, Rodriguez Luis, Vicente Esther, Gonzalez-Gay Miguel A, Mayes Maureen D, Tan Filemon K, Martin Javier, Arnett Frank |
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis and rheumatism 2009 Jan 60 (1): 225-33. Dieudé P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, Granel B, Sibilia J, Cabane J, Mouthon L, Cracowski J L, Carpentier P H, Hachulla E, Meyer O, Kahan A, Boileau C, Allanore |
Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection. Genes and immunity 2011 Jan 12 (1): 40-5. Vandenbroeck K, Alloza I, Swaminathan B, Antigüedad A, Otaegui D, Olascoaga J, Barcina M G, de las Heras V, Bartolomé M, Fernández-Arquero M, Arroyo R, Alvarez-Lafuente R, Cénit M C, Urcelay |
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.
Nature genetics 2010 May 42 (5): 426-9. Radstake Timothy R D J, Gorlova Olga, Rueda Blanca, Martin Jose-Ezequiel, Alizadeh Behrooz Z, Palomino-Morales Rogelio, Coenen Marieke J, Vonk Madelon C, Voskuyl Alexandre E, Schuerwegh Annemie J, Broen Jasper C, van Riel Piet L C M, van 't Slot Ruben, Italiaander Annet, Ophoff Roel A, Riemekasten Gabriela, Hunzelmann Nico, Simeon Carmen P, Ortego-Centeno Norberto, González-Gay Miguel A, González-Escribano María F, , Airo Paolo, van Laar Jaap, Herrick Ariane, Worthington Jane, Hesselstrand Roger, Smith Vanessa, de Keyser Filip, Houssiau Fredric, Chee Meng May, Madhok Rajan, Shiels Paul, Westhovens Rene, Kreuter Alexander, Kiener Hans, de Baere Elfride, Witte Torsten, Padykov Leonid, Klareskog Lars, Beretta Lorenzo, Scorza Rafaella, Lie Benedicte A, Hoffmann-Vold Anna-Maria, Carreira Patricia, Varga John, Hinchcliff Monique, Gregersen Peter K, Lee Annette T, Ying Jun, Han Younghun, Weng Shih-Feng, Amos Christopher I, Wigley Fredrick M, Hummers Laura, Nelson J Lee, Agarwal Sandeep K, Assassi Shervin, Gourh Pravitt, Tan Filemon K, Koeleman Bobby P C, Arnett Frank C, Martin Javier, Mayes Maureen |
Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. The Journal of rheumatology 2010 May 37 (5): 987-92. Dieude Philippe, Dawidowicz Karen, Guedj Mickaël, Legrain Yona, Wipff Julien, Hachulla Eric, Diot Elisabeth, Sibilia Jean, Mouthon Luc, Cabane Jean, Amoura Zahir, Crakowski Jean-Luc, Carpentier Patrick, Avouac Jerome, Meyer Olivier, Kahan Andre, Boileau Catherine, Allanore Yanni |
Association of the FAM167A-BLK region with systemic sclerosis. Arthritis and rheumatism 2010 Mar 62 (3): 890-5. Ito Ikue, Kawaguchi Yasushi, Kawasaki Aya, Hasegawa Minoru, Ohashi Jun, Kawamoto Manabu, Fujimoto Manabu, Takehara Kazuhiko, Sato Shinichi, Hara Masako, Tsuchiya Naoyu |
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Annals of the rheumatic diseases 2011 Apr 70 (4): 668-74. Dieudé P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Airo P, Melchers I, Hachulla E, Cerinic M Matucci, Diot E, Hunzelmann N, Caramaschi P, Sibilia J, Tiev K, Mouthon L, Riccieri V, Cracowski J L, Carpentier P H, Distler J, Amoura Z, Tarner I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore |
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonß therapy in multiple sclerosis. Genes and immunity 2011 Sep 12 (6): 466-72. Vosslamber S, van der Voort L F, van den Elskamp I J, Heijmans R, Aubin C, Uitdehaag B M J, Crusius J B A, van der Pouw Kraan T C T M, van der PouwKraan T C T M, Comabella M, Montalban X, Hafler D A, De Jager P L, Killestein J, Polman C H, Verweij C |
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Annals of the rheumatic diseases 2012 Jul 71 (7): 1197-202. Sharif Roozbeh, Mayes Maureen D, Tan Filemon K, Gorlova Olga Y, Hummers Laura Kathleen, Shah Ami A, Furst Daniel E, Khanna Dinesh, Martin Javier, Bossini-Castillo Lara, Gonzalez Emilio B, Ying Jun, Draeger Hilda Torres, Agarwal Sandeep K, Reveille John D, Arnett Frank C, Wigley Fredrick M, Assassi Sherv |
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13. Multiple sclerosis (Houndmills, Basingstoke, England) 2013 Jun 19 (7): 863-70. Lindén M, Khademi M, Lima Bomfim I, Piehl F, Jagodic M, Kockum I, Olsson |
The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. Journal of neuroimmunology 2013 Aug 261 (1-2): 92-7. Qiu Wei, Pham Kym, James Ian, Nolan David, Castley Allison, Christiansen Frank T, Czarniak Petra, Luo Yuebei, Wu Jingshan, Garlepp Michael, Wilton Steve, Carroll William M, Mastaglia Frank L, Kermode Allan |
The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PloS one 2013 8 (1): 1. Carmona FD, Martin JE, Beretta L, Simeón CP, Carreira PE, Callejas JL, Fernández-Castro M, Sáez-Comet L, Beltrán E, Camps MT, Egurbide MV, Airó P, Scorza R, Lunardi C, Hunzelmann N, Riemekasten G, Witte T, Kreuter A, Distler JH, Madhok R, Shiels P, van Laar JM, Fonseca C, Denton C, Herrick A, Worthington J, Schuerwegh AJ, Vonk MC, Voskuyl AE, Radstake TR, Martín J |
The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human molecular genetics 2015 Jan 24 (2): 582-96. Kottyan Leah C, Zoller Erin E, Bene Jessica, Lu Xiaoming, Kelly Jennifer A, Rupert Andrew M, Lessard Christopher J, Vaughn Samuel E, Marion Miranda, Weirauch Matthew T, Namjou Bahram, Adler Adam, Rasmussen Astrid, Glenn Stuart, Montgomery Courtney G, Hirschfield Gideon M, Xie Gang, Coltescu Catalina, Amos Chris, Li He, Ice John A, Nath Swapan K, Mariette Xavier, Bowman Simon, , Rischmueller Maureen, Lester Sue, Brun Johan G, Gøransson Lasse G, Harboe Erna, Omdal Roald, Cunninghame-Graham Deborah S, Vyse Tim, Miceli-Richard Corinne, Brennan Michael T, Lessard James A, Wahren-Herlenius Marie, Kvarnström Marika, Illei Gabor G, Witte Torsten, Jonsson Roland, Eriksson Per, Nordmark Gunnel, Ng Wan-Fai, , Anaya Juan-Manuel, Rhodus Nelson L, Segal Barbara M, Merrill Joan T, James Judith A, Guthridge Joel M, Scofield R Hal, Alarcon-Riquelme Marta, Bae Sang-Cheol, Boackle Susan A, Criswell Lindsey A, Gilkeson Gary, Kamen Diane L, Jacob Chaim O, Kimberly Robert, Brown Elizabeth, Edberg Jeffrey, Alarcón Graciela S, Reveille John D, Vilá Luis M, Petri Michelle, Ramsey-Goldman Rosalind, Freedman Barry I, Niewold Timothy, Stevens Anne M, Tsao Betty P, Ying Jun, Mayes Maureen D, Gorlova Olga Y, Wakeland Ward, Radstake Timothy, Martin Ezequiel, Martin Javier, Siminovitch Katherine, Moser Sivils Kathy L, Gaffney Patrick M, Langefeld Carl D, Harley John B, Kaufman Kenneth |
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis. Genetics and molecular research : GMR 2014 13 (2): 4473-85. Tang L, Chen B, Ma B, Nie |
Prediction of response to interferon therapy in multiple sclerosis. Acta neurologica Scandinavica 2014 Oct 130 (4): 268-75. Sellebjerg F, Søndergaard H B, Koch-Henriksen N, Sørensen P S, Oturai A |
Variants of Interferon Regulatory Factor 5 are Associated with Neither Neuromyelitis Optica Nor Multiple Sclerosis in the Southeastern Han Chinese Population. Chinese medical journal 2015 Jul 128 (13): 1743-7. Liu Qi-Bing, Wu Lei, Zhao Gui-Xian, Cai Ping-Ping, Li Zhen-Xin, Wu Zhi-Yi |
Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis. International journal of dermatology 2015 Dec . Xu Yang, Wang Wenling, Tian Yanli, Liu Jingyang, Yang Rong |
Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese. International journal of immunopathology and pharmacology 0 27 (4): 635-8. Wang J, Yi L, Guo X, Liu M, Li H, Zou H, Gu Y, Tu W, Guo G, Yang L, Lai S, He D, Zhou |
Analysis of Systemic Sclerosis-associated Genes in a Turkish Population. The Journal of rheumatology 2016 May . Carmona F David, Onat Ahmet Mesut, Fernández-Aranguren Tamara, Serrano-Fernández Alberto, Robledo Gema, Direskeneli Haner, Sawalha Amr H, Yavuz Sule, Martín Javi |
The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms. Rheumatology international 2017 Aug 37 (8): 1303-1310. Zhao Wenjie, Yue Xiaoyang, Liu Kuai, Zheng Junfeng, Huang Runda, Zou Jun, Riemekasten Gabriela, Petersen Frank, Yu Xinh |
Noncoding Variants as Genetic Contributors to Autoimmune Disease Pathogenesis. The Journal of investigative dermatology 2020 1 140 (2): 277-278. Javier Ellen, Lu Xiaoming, Kottyan Leah |
Cross-reactivity between Mycobacterium avium subspecies paratuberculosis 4027 peptide and Human IRF5 may contribute to Multiple Sclerosis in Iranian patients. Heliyon 2023 11 9 (11): e22137. Negar Asgari, Ezzat Allah Ghaemi, Mohammad Hasan Naeimi, Alireza Tahamtan, Leonardo Antonio Sechi, Samin Zama |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: